Titlebook: Cell Substrates; Their Use in the Pro John C. Petricciani,Hope E. Hopps,Paul J. Chapple Book 1979 The Editor(s) (if applicable) and The Aut

agnostic

旧石器时代

Interferon as a Cell Productactual application of interferon in clinical practice. Today we are at a stage when practical sources of human interferon for clinical trials are finally being developed and it is becoming possible to produce quantities of interferon that — though still relatively modest — will allow a thorough eval

不可比拟

脱离

Production of Biologicals by Plant Cell Culturesbecause the production of a biological by plant cell cultures on commercial scale may be operational within five years. The primary purpose of this chapter is to review the current state of knowledge of plant cell culture as it bears on the production of biologicals.

破译密码

outrage

Molecular Biology and Public Healthator. I hereby blame it on June Osborn, who may also deny it. My version of its history goes back to a telephone conversation with June during which time she lured me into attending this meeting, an invitation I accepted with alacrity. After agreeing to come, she said ever so sweetly: Of course, you

吗啡

Introductory Remarkss as substrates and the philosophy regarding choice of primary versus continuous cell lines. In addition, we have discussed the use of such cells in the production of newer, live viral vaccines and future needs in regard to the development of new inactivated vaccines and biologicals such as interfer

大量杀死

Benefit-Risk Assessmentxciting new technologies and their obvious- utilities. Speakers and discussants led us onto a mountain of expectation. They portrayed the possibilities and probabilities of cell substrates capable of making vaccines and other biologicals more precise and of higher quality than would otherwise be pos

intoxicate

Cell Substrates for Biologics Production: Factors Affecting Acceptabilityuse new data have been developed at a rapid rate over the past decade in the biological sciences, and because there has been a large experience with cells from a variety of sources in vaccine production, it is of interest to examine which criteria are of major importance in assessing the acceptabili